Past Events
Learn about past events and access related resources.
Image
Showing 120 Results
NPC Participates in the 2024 National Alliance Annual Forum
Members of the NPC leadership team will participate in discussions hosted by the National Alliance of Healthcare Purchaser Coalitions.
NPC Heads to AcademyHealth's 2024 Annual Research Meeting
Join NPC at this year's AcademyHealth 2024 Annual Research Meeting, where participants will learn about NPC's latest research.
John O'Brien to Speak at Model N’s Rainmaker24
NPC's President and CEO John M. O'Brien will participate in a panel session during the Model N Rainmaker24 event in Austin, TX.
NPC Leadership to Speak at BIO 2024
NPC's John O'Brien and Jon Campbell will serve as expert panelists during the conference.
NPC's John O'Brien to Speak at the Financial Times Live U.S. Pharma and Biotech Summit
Join NPC President and CEO John O'Brien in NYC (or virtually from around the world) on May 16 for a panel on "Solving the U.S. Drug Pricing Problem."
NPC at ISPOR 2024
The NPC team is heading to ISPOR 2024 to present research findings and to examine complex topics in pricing and value assessment. Will you be there? If so, let us know!
NPC's John O'Brien to Speak at Asembia's AXS24 Summit
Join NPC's John M. O'Brien, PharmD, MPH during Asembia's Specialty Pharmacy Summit in in Las Vegas.
NPC at AMCP 2024 Annual Meeting
Members of the NPC team will participate in sessions and present research findings.
NPC's John O'Brien to Speak at the ACCESS 2024 International Meeting & Expo
NPC's John O'Brien will serve as a guest expert to discuss the impacts of the Inflation Reduction Act.
NPC's John O'Brien to Speak at Pharma & Patient USA 2023
NPC's John O'Brien will serve as a guest expert at an event hosted by Reuters Events, and will help unpack the potential impacts of the Inflation Reduction Act and how stakeholders can work to…
NPC's Jon Campbell to Speak at ISPOR Europe 2023
NPC's Jon Campbell will moderate a panel discussion on overcoming the challenges of paying for expensive, but effective and potentially curative gene and other advanced therapy medicinal products.